IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Healthcare sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 50GRADE C+
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
12.7%
Sector: -43.5%
Dividend Analysis audit
No Dividend
This company does not currently pay a dividend.
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, NATURES SUNSHINE PRODUCTS INC (NATR) receives a "Hold" rating with a composite score of 54.8/100, ranked #634 out of 4446 stocks. Key factor scores: Quality 50/100, Value 62/100, Momentum 70/100. This is quantitative analysis only — not investment advice.
NATURES SUNSHINE PRODUCTS INC (NATR) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does NATURES SUNSHINE PRODUCTS INC Do?
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah. NATURES SUNSHINE PRODUCTS INC (NATR) is classified as a small-cap stock in the Healthcare sector, specifically within the Pharmaceutical Products industry. The company is led by CEO Terrence O. Moorehead and employs approximately 850 people, headquartered in LEHI, Utah. With a market capitalization of $428M, NATR is one of the notable companies in the Healthcare sector.
As of April 2026, NATURES SUNSHINE PRODUCTS INC receives a Hold rating with a composite score of 54.8/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.NATR ranks #634 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, NATURES SUNSHINE PRODUCTS INC ranks #37 of 838 stocks, placing it in the top 10% of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
NATR Stock Price and 52-Week Range
NATURES SUNSHINE PRODUCTS INC (NATR) currently trades at $26.92. The stock lost $0.13 (0.5%) in the most recent trading session. The 52-week high for NATR is $27.95, which means the stock is currently trading -3.7% from its annual peak. The 52-week low is $11.01, putting the stock 144.5% above its annual trough. Recent trading volume was 20K shares, suggesting relatively thin trading activity.
Is NATR Overvalued or Undervalued? — Valuation Analysis
NATURES SUNSHINE PRODUCTS INC (NATR) carries a value factor score of 62/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 21.13x, compared to the Healthcare sector average of 23.63x — a discount of 11%. The price-to-book ratio stands at 2.69x, versus the sector average of 2.75x. The price-to-sales ratio is 0.92x, compared to 1.66x for the average Healthcare stock. On an enterprise value basis, NATR trades at 17.60x EV/EBITDA, versus 6.34x for the sector.
Overall, NATR's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
NATURES SUNSHINE PRODUCTS INC (NATR) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 12.7%, compared to the Healthcare sector average of -43.5%, which is within a healthy range. Return on assets (ROA) comes in at 7.9% versus the sector average of -33.1%.
On a margin basis, NATURES SUNSHINE PRODUCTS INC reports gross margins of 72.1%, compared to 71.5% for the sector. The operating margin is 5.2% (sector: -66.1%). Net profit margin stands at 4.4%, versus -58.7% for the average Healthcare stock. Revenue growth is running at 16.1% on a trailing basis, compared to 10.6% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
NATR Debt, Balance Sheet, and Financial Health
NATURES SUNSHINE PRODUCTS INC has a debt-to-equity ratio of 62.0%, compared to the Healthcare sector average of 32.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 2.28x, indicating strong short-term liquidity. Total debt on the balance sheet is $0. Cash and equivalents stand at $96M.
NATR has a beta of 0.24, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for NATURES SUNSHINE PRODUCTS INC is 68/100, reflecting average volatility within the normal range for its sector.
NATURES SUNSHINE PRODUCTS INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, NATURES SUNSHINE PRODUCTS INC reported revenue of $471M and earnings per share (EPS) of $1.08. Net income for the quarter was $21M. Gross margin was 72.1%. Operating income came in at $25M.
In FY 2025, NATURES SUNSHINE PRODUCTS INC reported revenue of $480M and earnings per share (EPS) of $1.08. Net income for the quarter was $20M. Gross margin was 72.4%. Revenue grew 5.7% year-over-year compared to FY 2024. Operating income came in at $25M.
In Q3 2025, NATURES SUNSHINE PRODUCTS INC reported revenue of $128M and earnings per share (EPS) of $0.30. Net income for the quarter was $6M. Gross margin was 73.3%. Revenue grew 12.0% year-over-year compared to Q3 2024. Operating income came in at $9M.
In Q2 2025, NATURES SUNSHINE PRODUCTS INC reported revenue of $115M and earnings per share (EPS) of $0.29. Net income for the quarter was $6M. Gross margin was 71.7%. Revenue grew 3.8% year-over-year compared to Q2 2024. Operating income came in at $4M.
Over the past 8 quarters, NATURES SUNSHINE PRODUCTS INC has demonstrated a growth trajectory, with revenue expanding from $111M to $471M. Investors analyzing NATR stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
NATR Dividend Yield and Income Analysis
NATURES SUNSHINE PRODUCTS INC (NATR) does not currently pay a dividend. This is common among smaller companies in the Pharmaceutical Products industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.
NATR Momentum and Technical Analysis Profile
NATURES SUNSHINE PRODUCTS INC (NATR) has a momentum factor score of 70/100, indicating strong price momentum with the stock outperforming the majority of the market over recent periods. Stocks with high momentum scores have historically tended to continue their outperformance in the near term. The investment factor score is 27/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 36/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
NATR vs Competitors — Healthcare Sector Ranking and Peer Comparison
Comparing NATR against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full NATR vs S&P 500 (SPY) comparison to assess how NATURES SUNSHINE PRODUCTS INC stacks up against the broader market across all factor dimensions.
NATR Next Earnings Date
No upcoming earnings date has been announced for NATURES SUNSHINE PRODUCTS INC (NATR) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy NATR? — Investment Thesis Summary
NATURES SUNSHINE PRODUCTS INC presents a balanced picture with arguments on both sides. The value score of 62/100 suggests attractive pricing relative to fundamentals. Price momentum is positive at 70/100, suggesting the trend favors buyers. Low volatility (stability score 68/100) reduces downside risk.
In summary, NATURES SUNSHINE PRODUCTS INC (NATR) earns a Hold rating with a composite score of 54.8/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on NATR stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
NATURES SUNSHINE PRODUCTS INC (NATR) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
Nature's Sunshine Products (NATR) receives a Hold rating, reflecting a balanced view of its growth potential and inherent risks. While the company demonstrates strong profitability metrics compared to the healthcare sector and has shown recent revenue growth, concerns remain regarding its direct selling business model in an evolving regulatory landscape and the sustainability of its competitive advantages. The company's valuation appears reasonable, but not compelling enough to warrant a more bullish stance given the uncertainties.
The most critical takeaway is that Nature's Sunshine's future success hinges on its ability to adapt its distribution model to changing consumer preferences and regulatory scrutiny while maintaining its brand reputation and product quality. Investors should closely monitor the company's efforts to innovate its product offerings, expand its digital presence, and navigate the complexities of international markets.
Business Strategy & Overview
Nature's Sunshine Products operates within the natural health and wellness industry, manufacturing and distributing a range of nutritional and personal care products. The company's core strategy revolves around a direct selling model, relying on a network of independent consultants to market and sell its products directly to consumers. This model allows for personalized customer engagement and product education, which is particularly important in the health and wellness space where consumers often seek guidance and recommendations. The company operates under two primary brands: Nature's Sunshine, which focuses on general health and wellness products, and Synergy WorldWide, which targets the high-performance nutrition segment.
Geographically, Nature's Sunshine has a global presence, with operations in Asia, Europe, North America, and Latin America. This diversification helps mitigate regional economic risks and allows the company to capitalize on varying consumer preferences and market trends. However, it also introduces complexities related to regulatory compliance, currency fluctuations, and cultural differences. The company's product portfolio spans several categories, including general health, immunity, cardiovascular, digestive, and personal care. This broad offering aims to cater to a wide range of consumer needs and preferences, enhancing customer loyalty and repeat purchases.
Nature's Sunshine's strategic positioning within the industry is characterized by its focus on high-quality, science-backed products and its commitment to natural ingredients. This emphasis on quality and efficacy helps differentiate the company from competitors offering lower-priced or less rigorously tested products. The company invests in research and development to innovate its product offerings and stay ahead of emerging trends in the health and wellness market. This includes exploring new ingredients, formulations, and delivery methods to enhance product performance and appeal.
The direct selling industry is facing increasing scrutiny from regulators and consumers, particularly regarding deceptive marketing practices and pyramid scheme allegations. Nature's Sunshine must navigate these challenges by ensuring compliance with all applicable laws and regulations, promoting ethical business practices, and providing adequate training and support to its independent consultants. The company's ability to adapt its distribution model to changing consumer preferences and regulatory requirements will be crucial for its long-term success. This includes investing in digital marketing, e-commerce platforms, and social media engagement to reach a broader audience and enhance customer experience.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
16.1%
Sector: 10.6%
+51% VS SCTR
Economic Moat Analysis
Nature's Sunshine's economic moat is best characterized as Narrow. While the company possesses certain competitive advantages, they are not strong enough to create a wide and sustainable moat. The primary source of its moat stems from brand recognition and intangible assets, particularly its reputation for quality and efficacy in the natural health and wellness market. This reputation has been built over several decades and is supported by the company's commitment to scientific research and product development. However, brand loyalty in this sector can be fickle, and consumers are often willing to switch to alternative products or brands based on price, perceived benefits, or marketing campaigns.
Switching costs for consumers of Nature's Sunshine products are relatively low. While some customers may have developed a preference for specific products or routines, there are numerous alternative brands and products available in the market that offer similar benefits. The lack of significant switching costs makes it easier for competitors to attract customers away from Nature's Sunshine. The direct selling model, while providing personalized customer engagement, also presents challenges in terms of scalability and consistency. The reliance on independent consultants means that the customer experience can vary depending on the individual consultant's knowledge, skills, and motivation.
Network effects are not a significant factor in Nature's Sunshine's business model. While the company's network of independent consultants creates a distribution channel, it does not generate the same type of network effects seen in other industries, such as social media or online marketplaces. The value of the network does not increase exponentially as more consultants join, and there are limited barriers to entry for new consultants. Cost advantages are also not a primary source of Nature's Sunshine's moat. While the company may benefit from economies of scale in manufacturing and distribution, these advantages are not substantial enough to create a significant cost gap between Nature's Sunshine and its competitors. The company's focus on high-quality ingredients and rigorous testing also adds to its production costs, which may limit its ability to compete on price.
Efficient scale is not a relevant factor in this industry. The market for natural health and wellness products is highly fragmented, with numerous small and medium-sized players competing for market share. There are no significant barriers to entry for new competitors, and the industry is characterized by constant innovation and product differentiation. Nature's Sunshine's ability to maintain its narrow moat will depend on its continued investment in brand building, product innovation, and customer service. The company must also adapt its distribution model to changing consumer preferences and regulatory requirements to remain competitive in the long term.
Financial Health & Profitability
Nature's Sunshine Products demonstrates a mixed financial profile. The company's revenue has shown positive growth, with TTM revenue at $480.14 million, a 16.1% increase compared to the sector average of 10.7%. This growth is further evidenced by the consistent revenue increases observed in the quarterly financial history, from $445.32 million in FY2023 to $480.14 million in FY2025. This indicates a healthy demand for the company's products and effective sales strategies. However, the sustainability of this growth rate needs to be carefully monitored, especially given the competitive landscape and evolving consumer preferences.
Profitability metrics are generally strong compared to the healthcare sector. The company's gross margin of 72.1% is slightly above the sector average of 71.9%, indicating efficient cost management in production. Operating margin at 5.2% and net margin at 4.4% significantly outperform the sector averages of -65.2% and -54.1%, respectively. This suggests that Nature's Sunshine is effectively managing its operating expenses and generating profits from its core business activities. However, it's important to note that while these margins are positive, they are not exceptionally high, leaving room for improvement in operational efficiency.
The company's balance sheet is relatively strong, with total cash of $95.55 million and no debt. This provides financial flexibility for investments in growth initiatives, such as product development, marketing, and international expansion. The current ratio of 2.28 indicates a healthy level of liquidity, ensuring the company can meet its short-term obligations. The absence of debt also reduces financial risk and provides a competitive advantage in terms of capital allocation.
Return on Equity (ROE) of 12.7% is significantly higher than the sector average of -42.5%, indicating efficient use of shareholder equity to generate profits. This is a positive sign for investors, as it demonstrates the company's ability to create value. Free Cash Flow (FCF) generation is also positive, with $18.11 million TTM, further supporting the company's financial health and ability to fund future growth. However, the lack of quarterly FCF data limits the ability to assess the consistency and trend of cash flow generation.
Valuation Assessment
Nature's Sunshine Products' valuation presents a mixed picture. The company's P/E ratio of 22.0x is slightly lower than the healthcare sector average of 24.3x, suggesting that the stock may be modestly undervalued relative to its peers. However, P/E ratios can be misleading, especially when comparing companies with different growth rates and risk profiles. A more comprehensive valuation analysis is necessary to determine the true value of the stock.
The EV/EBITDA multiple of 4.2x is significantly lower than the sector average of 6.4x, indicating that the company may be undervalued based on its enterprise value relative to its earnings before interest, taxes, depreciation, and amortization. This multiple is particularly useful for comparing companies with different capital structures and tax rates. The low EV/EBITDA multiple suggests that the market may be undervaluing the company's earnings potential.
Given the company's recent revenue growth of 16.1%, a P/E ratio of 22.0x may be considered reasonable. However, the sustainability of this growth rate is a key factor in determining whether the stock is truly undervalued. If the company can maintain its current growth trajectory, the P/E ratio could be justified. However, if growth slows down, the stock may become overvalued.
The absence of FCF yield data makes it difficult to assess the company's valuation based on its free cash flow generation. FCF yield is a useful metric for determining the return an investor can expect from the company's free cash flow. A higher FCF yield generally indicates a more attractive valuation. Without this data, it's challenging to determine whether the stock is undervalued based on its cash flow generation.
Overall, Nature's Sunshine's valuation appears to be fair, but not compellingly cheap. The company's P/E and EV/EBITDA multiples suggest that the stock may be modestly undervalued relative to its sector peers. However, the lack of FCF yield data and the uncertainty surrounding the sustainability of its revenue growth make it difficult to argue that the stock is a bargain. Investors should carefully consider the company's growth prospects, competitive advantages, and risks before making an investment decision.
Risk & Uncertainty
Nature's Sunshine faces several specific risks that could impact its business and financial performance. One of the most significant risks is regulatory scrutiny of the direct selling industry. The company's business model relies on a network of independent consultants, which is subject to regulations regarding pyramid schemes and deceptive marketing practices. Increased regulatory enforcement could lead to fines, legal challenges, and restrictions on the company's operations. Maintaining compliance with all applicable laws and regulations is crucial for mitigating this risk.
Competition within the natural health and wellness industry is intense. The market is highly fragmented, with numerous companies offering similar products and services. Nature's Sunshine faces competition from both established players and emerging brands, which could put pressure on its market share and profitability. Differentiating its products and maintaining a strong brand reputation are essential for competing effectively in this market.
The company's reliance on independent consultants also presents a risk. The performance of the consultant network is critical to the company's sales and revenue growth. Factors such as consultant recruitment, training, and retention can impact the effectiveness of the network. The company must invest in supporting its consultants and ensuring they are properly trained and motivated to sell its products.
International operations expose Nature's Sunshine to currency fluctuations and geopolitical risks. The company operates in multiple countries, which means its financial results are subject to the impact of currency exchange rates. Political instability, economic downturns, and trade disputes in these regions could also negatively affect the company's business. Diversifying its geographic presence and hedging currency risks can help mitigate these risks.
Bulls Say / Bears Say
The Bull Case
BULL VIEWNature's Sunshine's strong balance sheet with no debt provides financial flexibility for strategic acquisitions and investments in growth initiatives, positioning the company for long-term success.
BULL VIEWThe company's superior profitability metrics compared to the healthcare sector, particularly its gross and operating margins, demonstrate efficient cost management and strong earnings potential.
BULL VIEWRecent revenue growth indicates increasing demand for Nature's Sunshine's products, suggesting the company is effectively capturing market share and capitalizing on consumer trends in the health and wellness industry.
The Bear Case
BEAR VIEWThe direct selling business model is increasingly under regulatory scrutiny, potentially leading to increased compliance costs and restrictions on Nature's Sunshine's operations.
BEAR VIEWIntense competition in the fragmented natural health and wellness market could erode Nature's Sunshine's market share and put pressure on its pricing power.
BEAR VIEWReliance on independent consultants creates operational risks, as their performance and retention directly impact the company's sales and revenue growth.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score NATR and 4,400+ other equities.
NATURES SUNSHINE PRODUCTS INC exhibits a 30% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
7.9%
Sector: -33.1%
Gross Margin
Pricing power and cost efficiency
72.1%
Sector: 71.5%
Operating Margin
Core business profitability
5.2%
Sector: -66.1%
Net Margin
Bottom-line profitability
4.4%
Sector: -58.7%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
